Regeneron Pharmaceuticals Inc (REGN)
962.20
-4.10
(-0.42%)
USD |
NASDAQ |
Mar 28, 16:00
962.38
+0.18
(+0.02%)
Pre-Market: 20:00
Regeneron Pharmaceuticals Total Return Level: 962.20 for March 28, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
March 28, 2024 | 962.20 |
March 27, 2024 | 966.30 |
March 26, 2024 | 963.55 |
March 25, 2024 | 961.09 |
March 22, 2024 | 967.24 |
March 21, 2024 | 968.01 |
March 20, 2024 | 966.96 |
March 19, 2024 | 963.66 |
March 18, 2024 | 959.92 |
March 15, 2024 | 964.47 |
March 14, 2024 | 959.04 |
March 13, 2024 | 965.47 |
March 12, 2024 | 970.57 |
March 11, 2024 | 964.44 |
March 08, 2024 | 968.83 |
March 07, 2024 | 973.31 |
March 06, 2024 | 972.10 |
March 05, 2024 | 965.21 |
March 04, 2024 | 971.19 |
March 01, 2024 | 982.82 |
February 29, 2024 | 966.09 |
February 28, 2024 | 987.61 |
February 27, 2024 | 993.35 |
February 26, 2024 | 989.28 |
February 23, 2024 | 981.20 |
Date | Value |
---|---|
February 22, 2024 | 964.89 |
February 21, 2024 | 952.84 |
February 20, 2024 | 946.87 |
February 16, 2024 | 948.05 |
February 15, 2024 | 954.73 |
February 14, 2024 | 947.82 |
February 13, 2024 | 940.48 |
February 12, 2024 | 947.06 |
February 09, 2024 | 953.42 |
February 08, 2024 | 946.43 |
February 07, 2024 | 938.49 |
February 06, 2024 | 937.81 |
February 05, 2024 | 936.33 |
February 02, 2024 | 945.18 |
February 01, 2024 | 957.78 |
January 31, 2024 | 942.78 |
January 30, 2024 | 959.73 |
January 29, 2024 | 955.80 |
January 26, 2024 | 940.05 |
January 25, 2024 | 948.87 |
January 24, 2024 | 948.24 |
January 23, 2024 | 954.58 |
January 22, 2024 | 942.83 |
January 19, 2024 | 933.40 |
January 18, 2024 | 930.00 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
273.46
Minimum
Sep 27 2019
993.35
Maximum
Feb 27 2024
601.66
Average
608.98
Median
Feb 23 2022
Total Return Level Benchmarks
Vertex Pharmaceuticals Inc | 418.01 |
Eli Lilly and Co | 2239.31 |
Pfizer Inc | 94.84 |
AbbVie Inc | 288.24 |
Puma Biotechnology Inc | 5.31 |